Is Na+/K+ ATPase A Target to Treat Parkinson's Disease?

Na+/K+-ATPase (NKA) plays important roles in maintaining cellular homeostasis. However, little is known about the function of NKA in the pathogenesis of Parkinson’s disease (PD). Here, we report that NKA activity is neuroprotective and that an antibody against the DR region of NKA represents a new therapeutic strategy for the treatment of PD.

Meeting ID: 882 8746 0057
Password: 673177

Asst Prof Alfred Sun
Principal Investigator
Neuroscience & Behavioural Disorders Programme, Duke-NUS

Contact Person
Jacqueline Ho (
Neuroscience & Behavioural Disorders Programme, Duke-NUS

Date and Time

09 Apr 2021 @ 12:00 - 09 Apr 2021 @ 13:00



Prof Bian Jinsong
Professor, Head of Department of Pharmacology
Southern University of Science and Technology

Prof Jinsong Bian earned his PhD degree from the University of Hong Kong in 2000.  He then went on to complete his post-doctoral training under an American Heart Association Fellowship at the Albert Einstein College of Medicine in New York, USA in 2003. He has published over 130 papers in journals including Cir Res, Sci Adv, JASN, Redox Biology. His main research interests include 1. Novel functions of Na+/K+ ATPase. 2. Biology of hydrogen sulfide.